Deep Track Capital as of Sept. 30, 2025
Portfolio Holdings for Deep Track Capital
Deep Track Capital holds 56 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Guardant Health (GH) | 7.2 | $260M | 4.2M | 62.48 | |
| Ionis Pharmaceuticals (IONS) | 7.0 | $249M | 3.8M | 65.42 | |
| Cytokinetics Com New (CYTK) | 6.6 | $236M | 4.3M | 54.96 | |
| Akero Therapeutics (AKRO) | 5.3 | $190M | 4.0M | 47.48 | |
| Apellis Pharmaceuticals (APLS) | 5.1 | $181M | 8.0M | 22.63 | |
| Tarsus Pharmaceuticals (TARS) | 5.0 | $178M | 3.0M | 59.43 | |
| Immunovant (IMVT) | 4.4 | $157M | 9.7M | 16.12 | |
| Dynavax Technologies Corp Com New (DVAX) | 4.4 | $156M | 16M | 9.93 | |
| Ocular Therapeutix (OCUL) | 3.9 | $140M | 12M | 11.69 | |
| 89bio (ETNB) | 3.8 | $138M | 9.4M | 14.70 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 3.3 | $118M | 4.2M | 28.00 | |
| Miragen Therapeutics (VRDN) | 3.2 | $116M | 5.4M | 21.58 | |
| Protagonist Therapeutics (PTGX) | 3.2 | $114M | 1.7M | 66.43 | |
| Axsome Therapeutics (AXSM) | 3.1 | $109M | 900k | 121.45 | |
| Vaxcyte (PCVX) | 3.0 | $108M | 3.0M | 36.02 | |
| Maze Therapeatics (MAZE) | 2.9 | $102M | 3.9M | 25.93 | |
| Immunocore Hldgs Ads (IMCR) | 1.8 | $65M | 1.8M | 36.33 | |
| Bridgebio Pharma (BBIO) | 1.7 | $62M | 1.2M | 51.94 | |
| Geron Corporation (GERN) | 1.6 | $56M | 41M | 1.37 | |
| Terns Pharmaceuticals (TERN) | 1.6 | $56M | 7.5M | 7.51 | |
| Nurix Therapeutics (NRIX) | 1.6 | $56M | 6.1M | 9.24 | |
| Mbx Biosciences (MBX) | 1.5 | $55M | 3.2M | 17.50 | |
| EXACT Sciences Corporation (EXAS) | 1.5 | $55M | 1.0M | 54.71 | |
| Lb Pharmaceuticals Com Shs | 1.5 | $53M | 3.4M | 15.79 | |
| Celldex Therapeutics Com New (CLDX) | 1.4 | $52M | 2.0M | 25.87 | |
| Oruka Therapeutics (ORKA) | 1.4 | $51M | 2.7M | 19.23 | |
| Xenon Pharmaceuticals (XENE) | 1.3 | $48M | 1.2M | 40.15 | |
| Compass Pathways Sponsored Ads (CMPS) | 1.3 | $45M | 7.9M | 5.73 | |
| Biosante Pharmaceuticals (ANIP) | 1.2 | $41M | 450k | 91.60 | |
| Bicara Therapeutics (BCAX) | 1.1 | $38M | 2.4M | 15.79 | |
| Olema Pharmaceuticals (OLMA) | 0.9 | $34M | 3.5M | 9.79 | |
| Cidara Therapeutics Com New (CDTX) | 0.8 | $29M | 300k | 95.76 | |
| Uniqure Nv SHS (QURE) | 0.8 | $28M | 483k | 58.37 | |
| Dyne Therapeutics (DYN) | 0.7 | $25M | 2.0M | 12.65 | |
| Jade Biosciences Com New (JBIO) | 0.5 | $20M | 2.3M | 8.63 | |
| Rapt Therapeutics Com New (RAPT) | 0.5 | $19M | 751k | 25.79 | |
| Gh Research Ordinary Shares (GHRS) | 0.5 | $18M | 1.3M | 14.30 | |
| Mind Medicine Mindmed Com New (MNMD) | 0.5 | $18M | 1.5M | 11.79 | |
| Engene Holdings (ENGN) | 0.4 | $15M | 2.2M | 6.83 | |
| Genmab A/s Sponsored Ads (GMAB) | 0.4 | $15M | 481k | 30.67 | |
| Tango Therapeutics (TNGX) | 0.3 | $12M | 1.5M | 8.40 | |
| Context Therapeutics (CNTX) | 0.2 | $7.2M | 7.4M | 0.97 | |
| Imagenebio | 0.2 | $7.2M | 879k | 8.15 | |
| Xencor (XNCR) | 0.2 | $6.4M | 549k | 11.73 | |
| Cybin Com New (CYBN) | 0.2 | $5.9M | 1.0M | 5.89 | |
| Cormedix Inc cormedix (CRMD) | 0.2 | $5.8M | 500k | 11.63 | |
| Pepgen (PEPG) | 0.2 | $5.5M | 1.2M | 4.62 | |
| Crescent Biopharma (CBIO) | 0.2 | $5.4M | 454k | 11.89 | |
| Aligos Therapeutics Com New (ALGS) | 0.1 | $4.4M | 444k | 9.80 | |
| Autolus Therapeutics Spon Ads (AUTL) | 0.1 | $4.2M | 2.6M | 1.63 | |
| X4 Pharmaceuticals (XFOR) | 0.1 | $3.8M | 1.1M | 3.42 | |
| ACADIA Pharmaceuticals (ACAD) | 0.1 | $2.2M | 105k | 21.34 | |
| Avalo Therapeutics Com New (AVTX) | 0.1 | $1.8M | 145k | 12.71 | |
| BioMarin Pharmaceutical (BMRN) | 0.0 | $1.3M | 25k | 54.16 | |
| Zura Bio Class A Ord Shs (ZURA) | 0.0 | $1.1M | 259k | 4.33 | |
| Eliem Therapeutics (CLYM) | 0.0 | $1.0M | 510k | 2.01 |
